source
- Mirador Therapeutics announces partnership to acquire Kira drug, positioning it against TavneosMirador Therapeutics, a San Diego‑based biotech focused on immune diseases and backed by more than $650 million in venture capital, has disclosed a new element of its development pipeline. The com…
- Veradermics' experimental hair loss pill shows promising results in womenVeradermics reported positive Phase 2 data for its oral minoxidil formulation VDPHL01 in women with mild-to-moderate pattern hair loss. The study enrolled 28 participants who took the drug once or…